Daye

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Daye is a gynecological health company that creates products and services for vaginal treatment.

HQ Location

London (United Kingdom)

Founded

2017

Employees

11 - 50

Total funding raised

$17.14M

Funding Status

Series A, $11.64M, October 26, 2022

Daye is a gynecological health company that creates products and services for vaginal treatment. Its tampon-based at-home vaginal microbiome screening kit allows women to test themselves at their leisure. The kit is intended to screen for vaginal infections such as thrush and bacterial vaginosis (BV), as well as disruptions to the microbiome, which could put women at risk of STIs, gynecological cancers, and fertility and IVF complications. Daye will also launch a comprehensive digital platform for gynae health, with the goal of reducing pain, shame, and wasted time for women as they navigate their health journey from their first period to menopause. The company was founded in 2017